Do Private Equity and Other Investors Harm Competition in the Pharmaceutical Industry? - ProMarket
Melissa Newham reviews how investors can alter the incentives and behavior of pharmaceutical companies to reduce competition and consumer welfare through common ownership and “rollup” deals.| ProMarket
